WASHINGTON, D.C. - When officials at Warner-Lambert Co. discovered they had a potentially life altering diabetes drug in production, they were thrilled. However, new documents show that research quickly showed the drug, Rezulin, caused liver damage.
Executives allegedly continued to promote the drug, which generated $2.1 billion in sales before being taken off the market three years after approval by officials at the Food and Drug Administration (FDA).
The drug was removed from store shelves because many liver-related deaths were linked to its use. New documents show Warner-Lambert executives may have known about this potentially lethal side effect from the beginning, but instead decided to conceal the information.
Pfizer Inc., which has since acquired Warner-Lambert, has turned information over to officials. More than 2,000 lawsuits have been filed for the 5,100 estimated Rezulin users.
Information from www.sfgate.com
Second Strain of Bird Flu Found in US Dairy Cows: What It Means for Infection Prevention and Control
February 7th 2025A new H5N1 strain was found in Nevada dairy cows, challenging earlier transmission theories. This raises concerns about animal vulnerability, human health risks, and food safety. Experts emphasize the need for improved surveillance, biosecurity, and cross-sector collaboration to contain the virus spread.